SCHEMBL24315849

SCHEMBL24315849

CC(C)C1CCCC(=O)NC1=O

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 18/20 0.41
DDB1 Q16531 15/20 0.38
POLB P06746 1/20 0.37
PDE9A O76083 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22623767 0.88 CRBN (0.44) CRBNDDB1POLB
SCHEMBL25046231 0.88 CRBN (0.44) CRBNDDB1POLB
SCHEMBL10073932 0.88 CRBN (0.44) CRBNDDB1POLB
SCHEMBL2956440 0.74 MAP3K14 (0.44) CRBNDDB1POLB
SCHEMBL20329585 0.72 CRBN (0.46) CRBNDDB1
SCHEMBL25467406 0.72 TLR4 (0.32) POLB
SCHEMBL765417 0.72
SCHEMBL2690883 0.72
SCHEMBL17427855 0.72
SCHEMBL10160076 0.71 L3MBTL1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed